Gene · 54567
Papers4,267
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,081 to 1,100 of 4,267
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Development of off-the-shelf hematopoietic stem cell-engineered invariant natural killer T cells for COVID-19 therapeutic intervention. | Stem Cell Res Ther | 2022 | 35313965 | PubTator, text mining | PubMed |
| Glycans that regulate Notch signaling in the intestine. | Biochem Soc Trans | 2022 | 35311893 | PubTator, text mining | PubMed |
| Glioblastoma Microenvironment: From an Inviolable Defense to a Therapeutic Chance. | Front Oncol | 2022 | 35311140 | PubTator, text mining | PubMed |
| Periosteum-derived podoplanin-expressing stromal cells regulate nascent vascularization during epiphyseal marrow development. | J Biol Chem | 2022 | 35304101 | PubTator, text mining | PubMed |
| Delivery of VEGF and delta-like 4 to synergistically regenerate capillaries and arterioles in ischemic limbs. | Acta Biomater | 2022 | 35301145 | PubTator, text mining | PubMed |
| Cadmium acute exposure induces metabolic and transcriptomic perturbations in human mature adipocytes. | Toxicology | 2022 | 35301059 | PubTator, text mining | PubMed |
| Publisher Correction: The endothelial Dll4-muscular Notch2 axis regulates skeletal muscle mass. | Nat Metab | 2022 | 35296870 | PubTator, text mining | PubMed |
| Potential biomarkers and the molecular mechanism associated with DLL4 during renal cell carcinoma progression. | Am J Med Sci | 2022 | 35289275 | PubTator, text mining | PubMed |
| Immobilized DLL4-induced Notch signaling is mediated by dynamics of the actin cytoskeleton. | Biochem Biophys Res Commun | 2022 | 35287005 | PubTator, text mining | PubMed |
| Identification of an evolutionarily conserved domain in Neurod1 favouring enteroendocrine versus goblet cell fate. | PLoS Genet | 2022 | 35286299 | PubTator, text mining | PubMed |
| Targeting Angiogenesis in Breast Cancer: Current Evidence and Future Perspectives of Novel Anti-Angiogenic Approaches. | Front Pharmacol | 2022 | 35281942 | PubTator, text mining | PubMed |
| Bisphenol chemicals disturb intestinal homeostasis via Notch/Wnt signaling and induce mucosal barrier dysregulation and inflammation. | Sci Total Environ | 2022 | 35278557 | PubTator, text mining | PubMed |
| 3D-organoid culture supports differentiation of human CAR+ iPSCs into highly functional CAR T cells. | Cell Stem Cell | 2022 | 35278370 | PubTator, text mining | PubMed |
| Trace Element-Augmented Titanium Implant With Targeted Angiogenesis and Enhanced Osseointegration in Osteoporotic Rats. | Front Chem | 2022 | 35273950 | PubTator, text mining | PubMed |
| Signaling pathways and targeted therapy for myocardial infarction. | Signal Transduct Target Ther | 2022 | 35273164 | PubTator, text mining | PubMed |
| Sex-specific involvement of the Notch-JAG pathway in social recognition. | Transl Psychiatry | 2022 | 35273151 | PubTator, text mining | PubMed |
| Elevated Kir2.1/nuclear N2ICD defines a highly malignant subtype of non-WNT/SHH medulloblastomas. | Signal Transduct Target Ther | 2022 | 35273141 | PubTator, text mining | PubMed |
| Damage-Associated Molecular Patterns (DAMPs) in Retinal Disorders. | Int J Mol Sci | 2022 | 35269741 | PubTator, text mining | PubMed |
| Cancer Stem Cells in Ovarian Cancer-A Source of Tumor Success and a Challenging Target for Novel Therapies. | Int J Mol Sci | 2022 | 35269636 | PubTator, text mining | PubMed |
| Dynamics of Endothelial Engagement and Filopodia Formation in Complex 3D Microscaffolds. | Int J Mol Sci | 2022 | 35269558 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54567/papers?page=55